• Home
  • About Us
  • Contact Us
  • Privacy Policy
  • Terms & Conditions
Monday, March 1, 2021
  • Home
  • Side Effects
  • Health Tips
  • Human Anatomy
No Result
View All Result
Side Effects
  • Home
  • Side Effects
  • Health Tips
  • Human Anatomy
No Result
View All Result
Side Effects
No Result
View All Result

Improving PET scans are good news for doctors and patients alike

Nina Anne Thompson by Nina Anne Thompson
February 8, 2021
in Health Tips
0 0
0
Improving PET scans are good news for doctors and patients alike
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

[ad_1]

A recent blog post discussed a newly approved imaging agent with an unwieldy name: gallium-68 PMA-11. Delivered in small amounts by injection, this minimally radioactive tracer sticks to prostate cancer cells, which subsequently glow and reveal themselves on a positron emission tomography (PET) scan. Offered to men with rising PSA levels after initial prostate cancer treatment (a condition called biochemical recurrence), this sort of imaging can allow doctors to find and treat new tumors that they might otherwise miss. With currently available imaging technology, such tumors could potentially escape detection until they were larger and more dangerous.

But while gallium-68 PMA-11 is the latest PET tracer to win FDA approval, not everyone can get it. In the United States, it’s currently available only to patients treated at the University of California, Los Angeles, or the University of California, San Francisco, where the tracer is manufactured. However, two other PET tracers approved for prostate cancer imaging in the US are becoming more accessible.

In January 2021, a team at Stanford University published findings showing that one those tracers, called fluciclovine F18 (trade name Axumin), identified significantly more metastatic cancers than other conventional types of imaging. Axumin was approved in 2016, and these are among the first data to show how well the tracer performs in real-world settings.

The Stanford researchers reviewed medical records from 165 men who had been given Axumin PET scans between September 2017 and December 2019. All the men had biochemical recurrence, and 70 of them were also imaged with other technologies, including CT scans, bone scans, or MRIs.

Axumin PET scans outperformed all the other tests with respect to tumor detection. In all, 110 men had PET-detected metastases, and no one with a negative PET scan was positive for cancer on other imaging tests. PET imaging found cancer in nine of 31 men who had negative results on CT scans. Similarly, six of 31 men with negative results on an MRI had PET-detected tumors. The technology also detected skeletal tumors in one man with a negative bone scan.

Importantly, tumor detection rates were greatest for men with high and rapidly rising PSA levels. That’s to be expected, since prostate cancer cells release PSA; as tumors grow and proliferate, PSA levels will rise in tandem. In fact, prior research shows that Axumin PET scans are unlikely to detect cancer if PSA is less than 1 nanogram per deciliter (ng/mL) in blood.

Positive PET scans also led to treatments that doctors might not have started if only negative findings with other imaging tests were available. Most of the 102 men who were subsequently treated got radiation delivered specifically to the tumor sites, in some instances combined with drugs that block testosterone, a hormone that speeds prostate cancer growth.

The study had some limitations, including that it was conducted at only one facility. Furthermore, in only seven cases were PET findings confirmed by a pathologist’s review of removed tissue samples. That’s because in most cases, the detected lesions were too small — less than a centimeter in size — to biopsy. PET-detected cancers were confirmed instead by declines in PSA after treatment.

“Axumin scanning, along with newly developed gallium scanning, is changing the way in which prostate cancer is staged and ultimately treated,” says Dr. Marc Garnick, the Gorman Brothers Professor of Medicine at Harvard Medical School and Beth Israel Deaconess Medical Center, editor of the Harvard Health Publishing Annual Report on Prostate Diseases, and editor in chief of HarvardProstateKnowledge.org. “The increased sensitivity of these new scanning technologies is both identifying patients with metastatic disease who otherwise would have been considered to be free of metastases, as well as helping to confirm the absence of metastatic deposits. Both situations will alter that way in which treatment decisions are made, and this will provide more precision in terms of what we can offer our patients. These new technologies are good news for doctors and patients alike.”

The post Improving PET scans are good news for doctors and patients alike appeared first on Harvard Health Blog.

[ad_2]

Source link

Tags: alikedoctorsGoodharvard health bloghealth bloghealth blogspotImprovingnewsPatientsPETscans
Previous Post

NY Doctor Proved Everyone Wrong About Hydroxychloroquine

Next Post

Usnic Acid Inhibits Viral Respiratory Infection

Nina Anne Thompson

Nina Anne Thompson

I'm Nina Anne Thompson. I am a final year medical student as well an entrepreneur. I've created this blog to share my health knowledge with the world.

Next Post
Usnic Acid Inhibits Viral Respiratory Infection

Usnic Acid Inhibits Viral Respiratory Infection

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

trintellix side effects
Side Effects

8 Must Know Facts on Trintellix Side Effects

by Nina Anne Thompson
September 7, 2019
0

Trintellix is a drug used to treat the patient suffering from depression and related problems. So, you might not familiar...

Read more

How many bones are in the human body?

September 15, 2019
flonase side effects

Flonase Side Effects and Current Medical Uses

September 2, 2019
Cbd pain cream

CBD Pain Cream is One of the Best Pain Relievers in 2020!

October 14, 2020

Could This Be the Answer to AFib, NAFLD and Other Diseases?

October 22, 2020

Follow Us

Recent Posts

best-lab-certified-cbd
Health Tips

Best lab-certified CBD – E1011 Labs – “E Ten Eleven Labs”

by Nina Anne Thompson
February 17, 2021
0

E1011 Labs endeavors to bring the next generation of self-care and personal wellness with innovative design and thoughtfully crafted formulations....

Read more
Health Officials Make Crucial Error in Vaccine Recommendation

Health Officials Make Crucial Error in Vaccine Recommendation

February 16, 2021
young woman with allergies

Can dust mite allergy be treated with a pill?

February 15, 2021
Thyme Extract Helps Treat COVID-19

Thyme Extract Helps Treat COVID-19

February 15, 2021
A reminder of the importance of blood and organ donation. Hands holding a heart with a message that reads: Organ donors save lives.

Flowers, chocolates, organ donation — are you in?

February 14, 2021
  • Home
  • About Us
  • Contact Us
  • Privacy Policy
  • Terms & Conditions
Contact Us - moresideeffects@gmail.com

Copyright © 2020 | Side Effects & Health Tips

No Result
View All Result
  • Home
  • Side Effects
  • Health Tips
  • Human Anatomy
  • Contact Us

Copyright © 2020 | Side Effects & Health Tips

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In